top of page
News, Events and Updates
Search
Jan 31, 2019
Anavex Life Sciences to Announce Fiscal 2019 First Quarter Financial Results on Thursday, 2/7/2019
Jan 2, 2019
Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer
Dec 12, 2018
Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update
Dec 10, 2018
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, 12/12/2018
Nov 8, 2018
Anavex Life Sciences Strengthens its Scientific Advisory Board with Distinguished Researcher for Cli
Oct 30, 2018
First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX®2-73
Oct 26, 2018
Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX®2-73
Oct 19, 2018
Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial ANAVEX®2-73 for Rett Syndrome
Sep 26, 2018
Anavex Life Sciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
Aug 28, 2018
First Patient Enrolled in Anavex Life Sciences Phase 2b/3 Clinical Trial of ANAVEX®2-73
Aug 9, 2018
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results
18
19
20
21
22
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
